Arkolith/Insider Trading/INMB/Form 4

Lowdell Mark William

Chief Scientific OfficerInmune Bio, Inc. (INMB) · full profile →Form 4 · filed Jul 7, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 2, 2026Option exercise(M)7K$1.40$10K1.5M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 2, 2026Option exercise(X)7K$0.13$9017K

Transaction Codes

M
Option exercise / conversion
X
Exercise of in-the-money derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-075737) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML